The orphanin FQ/nociceptin gene: Structure, tissue distribution of expression and functional implications obtained from knockout mice

Peptides

Volumn 21, Issue 7, 2000, Pages 901-906

  Reinscheid, Rainer K ^a   Nothacker, Hans Peter ^a   Civelli, Olivier ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesia; Anxiety; Dynorphin A; Gene regulation; Knockout mice; Neuropeptide precursor; Processing; Stress

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; NEUROPEPTIDE; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE RECEPTOR; PROTEIN PRECURSOR;

AMINO ACID SEQUENCE; ANALGESIA; ANIMAL TISSUE; ANXIETY; BRAIN REGION; CATTLE; COGNITION; EMOTION; EVOLUTION; GENE CONTROL; GENE EXPRESSION; GENE STRUCTURE; HUMAN; INFORMATION PROCESSING; KNOCKOUT MOUSE; LIMBIC SYSTEM; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOUSE; MUTANT; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; REVIEW; SENSORY SYSTEM; SPECIES DIFFERENCE; STRESS; SWINE; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OPIOID PEPTIDES; PEPTIDES; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; VASODILATOR AGENTS;

EID: 0033821691     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00226-6     Document Type: Review

References (52)

1. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol. 368:1996;229-251.
2. Bryant W., Janik J., Baumann M., Callahan P. Orphanin FQ stimulates prolactin and growth hormone release in male and female rats. Brain Res. 807:1998;228-233.
3. Bunzow J.R., Saez C., Mortrud M., et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta, or kappa opioid receptor type. FEBS Lett. 347:1994;284-288.
4. Butour J.L., Moisand C., Mazarguil H., Mollereau C., Meunier J.C. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol. 321:1997;97-103.
5. Buzas B., Rosenberger J., Cox B.M. Activity and cyclic AMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. J Neurochem. 71:1998;556-563.
6. Buzas B., Symes A.J., Cox B.M. Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. J Neurochem. 72:1999;1882-1889.
7. Danielson P.B., Dores R.M. Molecular evolution of the opioid/orphanin gene family. Gen Comp Endocrinol. 113:1999;169-186.
8. Florin S., Duauadeau C., Meunier J.C., Costentin J. Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice. Neuroreport. 8:1997;705-707.
9. 3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neurosci. Lett. 230:1997;33-36.
10. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem Biophys Res Commun. 219:1996;714-719.
11. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J Comp Neurol. 399:1999;139-151.
12. Jenck F., Moreau J.-L., Martin J.R., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA. 94:1997;14854-14858.
13. Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 1997;60P:L15-21.
14. Köster A., Montkowski A., Schulz S., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA. 96:1999;10444-10449.
15. Konya H., Masuda H., Itoh K., Nagai K., Kakishita E., Matsuoka A. Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res. 788:1998;341-344.
16. Lachowicz J.E., Shen Y., Monsma F.J. Jr, Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem. 64:1995;34-40.
17. Lai C.C., Wu S.Y., Dun S.L., Dun N.J. Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons. Neuroscience. 81:1997;887-891.
18. Lee T.L., Fung F.M., Chen F.G., et al. Identification of human, rat and mouse nocistatin in brain and human nocistatin in brain and human cerebrospinal fluid. Neuroreport. 10:1999;1537-1541.
19. Makman M.H., Lyman W.D., Dvorkin B. Presence and characterization of nociceptin (orphanin FQ) receptor binding in adult rat and human fetal hypothalamus. Brain Res. 762:1997;247-250.
20. Mamiya T., Noda M., Takeshima H., Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res. 783:1998;236-240.
21. Manabe T., Noda Y., Mamiya T., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
22. Meng F., Taylor L.P., Hoversten M.T., et al. Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem. 271:1996;32016-32020.
23. Meunier J.C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
24. Mogil J.S., Grisel J.E., Reinscheid R.K., et al. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
25. Mollereau C., Parmentier M., Mailleux P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
26. Mollereau C., Simons M.J., Soularue P., et al. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA. 93:1996;8666-8670.
27. Murphy N.P., Ly H.Y., Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience. 75:1996;1-4.
28. Neal C.R., Mansour A., Nothacker H.-P., Reinscheid R.K., Civelli O., Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the forebrain of the rat. J Comp Neurol. 406:1999;503-547.
29. Neal C.R., Mansour A., Reinscheid R.K., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol. 412:1999;563-605.
30. Nishi M., Houtani T., Noda Y., et al. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J. 16:1997;1858-1864.
31. Nothacker H.-P., Reinscheid R.K., Mansour A., et al. Primary structure and tissue distribution of the orphanin FQ recursor. Proc Natl Acad Sci USA. 93:1996;8677-8682.
32. Okuda-Ashitaka E., Minami T., Tachibana S., et al. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
33. Osinski M.A., Pampusch M.S., Murtaugh M.P., Brown D.R. Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the procine gastrointestinal tract. Eur J Pharmacol. 365:1999;281-289.
34. Pampusch MS, Serie JR, Osinski MA, Murtaugh MP, Brown DR. Localization of nociceptin (orphanin FQ) and its receptor in porcine tissue. GenBank Acct No. AA1999:D09312.
35. Pan Y.X., Xu J., Pasternak G.W. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem J. 315:1996;11-13.
36. Reinscheid R.K., Nothacker H.-P., Bourson A., et al. Orphanin FQ a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
37. Reinscheid R.K., Ardati A., Monsma F.J. Jr, Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem. 271:1996;14163-14168.
38. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J. Jr, Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J Biol Chem. 273:1998;1490-1495.
39. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. Neuroreport. 7:1996;1369-1372.
40. Rossi G.C., Mathis J.P., Pasternak G.W. Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ 141-157 in mice. Neuroreport. 9:1998;1165-1168.
41. Saito Y., Maruyama K., Saido T.C., Kawashima S. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem Biophys Res Commun. 217:1995;539-545.
42. Saito Y., Maruyama K., Kawano H., et al. Molecular cloning and characterization of a novel form of neuropeptide gene as a developmentally regulated molecule. J Biol Chem. 271:1996;15615-15622.
43. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9:1997;194-197.
44. Schuligoi R., Amann R., Angelberger P., Peskar B.A. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci Lett. 224:1997;136-138.
45. Schulz S., Schreff M., Nuss D., Gramsch C., Höllt V. Nociceptin/orphanin FQ, and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. Neuroreport. 7:1996;3021-3025.
46. 35S]GTP gamma S binding in rat brain. Neuroreport. 7:1996;729-733.
47. Sirianni M.J., Fujimoto K.I., Nelson C.S., Pellegrino M.J., Allen R.G. Cyclic AMP analogs induce synthesis, processing, and secretion of prepro nociceptin/orphanin FQ-derived peptides by NS20Y neuroblastoma cells. DNA Cell Biol. 18:1999;51-58.
48. Tian J.H., Zhang W., Fang Y., Xu W., Grandy D.K., Han J.S. Endogenous orphanin FQ evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. Br J Pharmacol. 124:1998;21-26.
49. Ueda H., Yamaguchi T., Tokuyama S., Inoue M., Nishi M., Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett. 237:1997;136-138.
50. Wang J.B., Johnson P.S., Imai Y., et al. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
51. Xie G., Ito E., Maruyama K., Suzuki Y., Sugano S., Sharma M., Pietruck C., Palmer P.P. The promoter region of the human prepro-nociceptin gene and its regulation by cyclic AMP and steroid hormones. Gene. 238:1999;427-436.
52. Yazdani A., Takahashi T., Bagnol D., Watson S.J., Owyang C. Functional significance of a newly discovered neuropeptide, orphanin FQ, in rat gastrointestinal motility. Gastroenterology. 116:1999;108-117.